Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 - 2024
This report can be delivered to the clients within 48 Hours
The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.
Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.
Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.
Further key findings from the study suggest:
The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.
Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.
Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.
Further key findings from the study suggest:
- PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing
- The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth
- In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase
- North America captured the largest revenue share in 2016 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
- Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, medical tourism industry, and awareness regarding organ donation
- Some major players in this market are Thermo Fisher Scientific, Inc.; Illumina, Inc.; F.Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis& Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 TRANSPLANT DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Increasing awareness leading to increasing organ donations
3.2.2 Technological advancements
3.2.3 Increase in disease diagnosis
3.2.4 Regulatory guidelines for organ transplant
3.3 Market Restraints Analysis
3.3.1 Insurance and reimbursement polices
3.3.2 High cost of organ transplant
3.3.3 Social and ethical issues related to organ transplant
3.4 Penetration & growth prospect mapping
3.5 Transplant Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
CHAPTER 4 TRANSPLANT DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1 Transplant diagnostics market: technology movement analysis
4.2 Molecular
4.2.1 Molecular Market, 2014 - 2024 (USD Million)
4.2.2 PCR Based Molecular Assays
4.2.2.1 PCR Based Assay Market, 2014 - 2024 (USD Million)
4.2.3 Sequencing Based Molecular Assays
4.2.3.1 Sequencing Based Assay Market, 2014 - 2024 (USD Million)
4.3 Non Molecular
4.3.1 Non- Molecular Market, 2014 - 2024 (USD Million)
4.3.2 Serological Assays
4.3.2.1 Serological Assay Market, 2014 - 2024 (USD Million)
4.3.3 Mixed Lymphocyte Culture (MLC) Assays
4.3.3.1 Mixed Lymphocyte Culture Assay Market, 2014 - 2024 (USD Million)
CHAPTER 5 TRANSPLANT DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Transplant Diagnostics Market: Product Movement Analysis
5.2 Reagents and Consumables
5.2.1 Reagents and Consumables Market, 2014 - 2024 (USD Million)
5.3 Instrument
5.3.1 Instrument Market, 2014 - 2024 (USD Million)
5.4 Software and Services
5.4.1 Software and Services Market, 2014 - 2024 (USD Million)
CHAPTER 6 TRANSPLANT DIAGNOSTIC MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY & PRODUCT TYPE
6.1 North America
6.1.1 North America Market, 2014 - 2024 (USD Million)
6.1.2 U.S.
6.1.3 U.S. Market, 2014 - 2024 (USD Million)
6.1.4 Canada
6.1.5 Canada Market, 2014 - 2024 (USD Million)
6.2 Europe
6.2.1 Europe Market, 2014 - 2024 (USD Million)
6.2.2 U.K.
6.2.3 U.K. Market, 2014 - 2024 (USD Million)
6.2.4 Germany
6.2.5 Germany Market, 2014 - 2024 (USD Million)
6.3 Asia Pacific
6.3.1 Asia Pacific Market, 2014 - 2024 (USD Million)
6.3.2 Japan
6.3.3 Japan Market, 2014 - 2024 (USD Million)
6.3.4 India
6.3.5 India Market, 2014 - 2024 (USD Million)
6.4 Latin America
6.4.1 Latin America Market, 2014 - 2024 (USD Million)
6.4.2 Brazil
6.4.3 Brazil Market, 2014 - 2024 (USD Million)
6.4.4 Mexico
6.4.5 Mexico Market, 2014 - 2024 (USD Million)
6.5 Middle East and Africa (MEA)
6.5.1 Middle East & Africa Market, 2014 - 2024 (USD Million)
6.5.2 South Africa
6.5.3 South Africa Market, 2014 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Thermo Fisher Scientific, Inc.
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 QIAGEN
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Illumina, Inc.
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 F. Hoffmann La-Roche Ltd
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Abbott
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Bio-Rad Laboratories Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 IMMUCOR
7.1.7.1 Company Overview
7.1.7.2 Product Benchmarking
7.1.7.3 Strategic Initiatives
7.1.8 Omixon Inc.
7.1.8.1 Company Overview
7.1.8.2 Product Benchmarking
7.1.8.3 Strategic Initiatives
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis& Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 TRANSPLANT DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Increasing awareness leading to increasing organ donations
3.2.2 Technological advancements
3.2.3 Increase in disease diagnosis
3.2.4 Regulatory guidelines for organ transplant
3.3 Market Restraints Analysis
3.3.1 Insurance and reimbursement polices
3.3.2 High cost of organ transplant
3.3.3 Social and ethical issues related to organ transplant
3.4 Penetration & growth prospect mapping
3.5 Transplant Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
CHAPTER 4 TRANSPLANT DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1 Transplant diagnostics market: technology movement analysis
4.2 Molecular
4.2.1 Molecular Market, 2014 - 2024 (USD Million)
4.2.2 PCR Based Molecular Assays
4.2.2.1 PCR Based Assay Market, 2014 - 2024 (USD Million)
4.2.3 Sequencing Based Molecular Assays
4.2.3.1 Sequencing Based Assay Market, 2014 - 2024 (USD Million)
4.3 Non Molecular
4.3.1 Non- Molecular Market, 2014 - 2024 (USD Million)
4.3.2 Serological Assays
4.3.2.1 Serological Assay Market, 2014 - 2024 (USD Million)
4.3.3 Mixed Lymphocyte Culture (MLC) Assays
4.3.3.1 Mixed Lymphocyte Culture Assay Market, 2014 - 2024 (USD Million)
CHAPTER 5 TRANSPLANT DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Transplant Diagnostics Market: Product Movement Analysis
5.2 Reagents and Consumables
5.2.1 Reagents and Consumables Market, 2014 - 2024 (USD Million)
5.3 Instrument
5.3.1 Instrument Market, 2014 - 2024 (USD Million)
5.4 Software and Services
5.4.1 Software and Services Market, 2014 - 2024 (USD Million)
CHAPTER 6 TRANSPLANT DIAGNOSTIC MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY & PRODUCT TYPE
6.1 North America
6.1.1 North America Market, 2014 - 2024 (USD Million)
6.1.2 U.S.
6.1.3 U.S. Market, 2014 - 2024 (USD Million)
6.1.4 Canada
6.1.5 Canada Market, 2014 - 2024 (USD Million)
6.2 Europe
6.2.1 Europe Market, 2014 - 2024 (USD Million)
6.2.2 U.K.
6.2.3 U.K. Market, 2014 - 2024 (USD Million)
6.2.4 Germany
6.2.5 Germany Market, 2014 - 2024 (USD Million)
6.3 Asia Pacific
6.3.1 Asia Pacific Market, 2014 - 2024 (USD Million)
6.3.2 Japan
6.3.3 Japan Market, 2014 - 2024 (USD Million)
6.3.4 India
6.3.5 India Market, 2014 - 2024 (USD Million)
6.4 Latin America
6.4.1 Latin America Market, 2014 - 2024 (USD Million)
6.4.2 Brazil
6.4.3 Brazil Market, 2014 - 2024 (USD Million)
6.4.4 Mexico
6.4.5 Mexico Market, 2014 - 2024 (USD Million)
6.5 Middle East and Africa (MEA)
6.5.1 Middle East & Africa Market, 2014 - 2024 (USD Million)
6.5.2 South Africa
6.5.3 South Africa Market, 2014 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Thermo Fisher Scientific, Inc.
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 QIAGEN
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Illumina, Inc.
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 F. Hoffmann La-Roche Ltd
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Abbott
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Bio-Rad Laboratories Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 IMMUCOR
7.1.7.1 Company Overview
7.1.7.2 Product Benchmarking
7.1.7.3 Strategic Initiatives
7.1.8 Omixon Inc.
7.1.8.1 Company Overview
7.1.8.2 Product Benchmarking
7.1.8.3 Strategic Initiatives
LIST OF TABLES
Table 1 Transplant Diagnostics Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
Table 2 Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 3 Transplant Diagnostics Market Revenue, by Region, 2014 - 2024 (USD Million)
Table 4 Transplant Diagnostics - Key market driver analysis
Table 5 Transplant Diagnostics - Key market restraints analysis
Table 6 North America Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 7 North America Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 8 U.S. Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 9 U.S. Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 10 Canada Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 11 Canada Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 12 Europe Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 13 Europe Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 14 U.K. Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 15 U.K. Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 16 Germany Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 17 Germany Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 18 Asia Pacific Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 19 Asia Pacific Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 20 Japan Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 21 Japan Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 22 India Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 23 India Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 24 Latin America Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 25 Latin America Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 26 Brazil Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 27 Brazil Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 28 Mexico Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 29 Mexico Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 30 Middle East & Africa Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 31 Middle East & Africa Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 32 South Africa Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 33 South Africa Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 1 Transplant Diagnostics Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
Table 2 Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 3 Transplant Diagnostics Market Revenue, by Region, 2014 - 2024 (USD Million)
Table 4 Transplant Diagnostics - Key market driver analysis
Table 5 Transplant Diagnostics - Key market restraints analysis
Table 6 North America Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 7 North America Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 8 U.S. Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 9 U.S. Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 10 Canada Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 11 Canada Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 12 Europe Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 13 Europe Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 14 U.K. Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 15 U.K. Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 16 Germany Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 17 Germany Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 18 Asia Pacific Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 19 Asia Pacific Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 20 Japan Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 21 Japan Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 22 India Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 23 India Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 24 Latin America Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 25 Latin America Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 26 Brazil Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 27 Brazil Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 28 Mexico Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 29 Mexico Transplant Diagnostics Market Revenue, by Product , 2014 - 2024 (USD Million)
Table 30 Middle East & Africa Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 31 Middle East & Africa Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
Table 32 South Africa Transplant Diagnostics Market Revenue, by Technology, 2014 - 2024 (USD Million)
Table 33 South Africa Transplant Diagnostics Market Revenue, by Product, 2014 - 2024 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market summary, USD Million, 2016
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Penetration & Growth prospect mapping
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Transplant Diagnostics Market Technology Outlook Key Takeaways
Fig. 16 Transplant Diagnostics: Technology Movement Analysis
Fig. 17 Molecular Market, 2014 - 2024 (USD Million)
Fig. 18 PCR Based Assay Market, 2014 - 2024 (USD Million)
Fig. 19 Sequencing Based Assay Market, 2014 - 2024 (USD Million)
Fig. 20 Non - Molecular Market, 2014 - 2024 (USD Million)
Fig. 21 Serological Assay Market, 2014 - 2024 (USD Million)
Fig. 22 Mixed Lymphocyte Culture Assay Market, 2014 - 2024 (USD Million)
Fig. 23 Transplant Diagnostics Market: Product Outlook Key Takeaways
Fig. 24 Transplant Diagnostics : Product Movement Analysis
Fig. 25 Reagents and Consumables Market, 2014 - 2024 (USD Million)
Fig. 26 Instrument Market, 2014 - 2024 (USD Million)
Fig. 27 Software and Services Market, 2014 - 2024 (USD Million)
Fig. 28 Regional market place: Key takeaways
Fig. 29 North America Market, 2014 - 2024 (USD Million)
Fig. 30 U.S. Market, 2014 - 2024 (USD Million)
Fig. 31 Canada Market, 2014 - 2024 (USD Million)
Fig. 32 Europe Market, 2014 - 2024 (USD Million)
Fig. 33 U.K. Market, 2014 - 2024 (USD Million)
Fig. 34 Germany Market, 2014 - 2024 (USD Million)
Fig. 35 Asia Pacific Market, 2014 - 2024 (USD Million)
Fig. 36 Japan Market, 2014 - 2024 (USD Million)
Fig. 37 India Market, 2014 - 2024 (USD Million)
Fig. 38 Latin America Market, 2014 - 2024 (USD Million)
Fig. 39 Brazil Market, 2014 - 2024 (USD Million)
Fig. 40 Mexico Market, 2014 - 2024 (USD Million)
Fig. 41 Middle East & Africa Market, 2014 - 2024 (USD Million)
Fig. 42 South Africa Market, 2014 - 2024 (USD Million)
Fig. 43 Strategy framework
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market summary, USD Million, 2016
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Penetration & Growth prospect mapping
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Transplant Diagnostics Market Technology Outlook Key Takeaways
Fig. 16 Transplant Diagnostics: Technology Movement Analysis
Fig. 17 Molecular Market, 2014 - 2024 (USD Million)
Fig. 18 PCR Based Assay Market, 2014 - 2024 (USD Million)
Fig. 19 Sequencing Based Assay Market, 2014 - 2024 (USD Million)
Fig. 20 Non - Molecular Market, 2014 - 2024 (USD Million)
Fig. 21 Serological Assay Market, 2014 - 2024 (USD Million)
Fig. 22 Mixed Lymphocyte Culture Assay Market, 2014 - 2024 (USD Million)
Fig. 23 Transplant Diagnostics Market: Product Outlook Key Takeaways
Fig. 24 Transplant Diagnostics : Product Movement Analysis
Fig. 25 Reagents and Consumables Market, 2014 - 2024 (USD Million)
Fig. 26 Instrument Market, 2014 - 2024 (USD Million)
Fig. 27 Software and Services Market, 2014 - 2024 (USD Million)
Fig. 28 Regional market place: Key takeaways
Fig. 29 North America Market, 2014 - 2024 (USD Million)
Fig. 30 U.S. Market, 2014 - 2024 (USD Million)
Fig. 31 Canada Market, 2014 - 2024 (USD Million)
Fig. 32 Europe Market, 2014 - 2024 (USD Million)
Fig. 33 U.K. Market, 2014 - 2024 (USD Million)
Fig. 34 Germany Market, 2014 - 2024 (USD Million)
Fig. 35 Asia Pacific Market, 2014 - 2024 (USD Million)
Fig. 36 Japan Market, 2014 - 2024 (USD Million)
Fig. 37 India Market, 2014 - 2024 (USD Million)
Fig. 38 Latin America Market, 2014 - 2024 (USD Million)
Fig. 39 Brazil Market, 2014 - 2024 (USD Million)
Fig. 40 Mexico Market, 2014 - 2024 (USD Million)
Fig. 41 Middle East & Africa Market, 2014 - 2024 (USD Million)
Fig. 42 South Africa Market, 2014 - 2024 (USD Million)
Fig. 43 Strategy framework
